Evidence map›Paper›PMID 32459796›Full record

ArticleThe American journal of case reports2020

Membranoproliferative Glomerulonephritis and Mixed Cryoglobulinemia as a Form of Presentation of Visceral Leishmaniasis.

Maite Padrón Romero, Mercedes M Acevedo Ribó, Francisco Javier Ahijado Hormigos, Francisco Díaz Crespo, Laura Cueto Bravo, Cristina Herraiz Corredor, María Ángeles Fernández Rojo, Rafael Díaz-Tejeiro Izquierdo

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Renal Alterations Secondary to Visceral Leishmaniasis: A Scoping Review.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maite Padrón RomeroDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
Mercedes M Acevedo RibóDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
Francisco Javier Ahijado HormigosDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
Francisco Díaz CrespoDepartment of Pathology, Virgin Health Hospital, Toledo, Spain.
Laura Cueto BravoDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
Cristina Herraiz CorredorDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
María Ángeles Fernández RojoDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.
Rafael Díaz-Tejeiro IzquierdoDepartment of Nephrology, Virgin Health Hospital, Toledo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Visceral leishmaniasis (VL) is an endemic systemic disease in the Mediterranean countries, including Spain. This vector-borne infection can present with several clinical presentations, from asymptomatic to severe forms. Renal impairment is frequently described in VL but is usually mild and related to interstitial nephritis, being that glomerular involvement is rarely found. CASE REPORT We describe a case of a 69-year-old Spanish male presenting with subacute renal failure due to membranoproliferative glomerulonephritis and mixed cryoglobulinemia accompanied by other autoimmune features (hypocomplementemia, antinuclear and antiDNA antibodies). No hepatosplenomegaly was found with abdominal ultrasound. Hepatotropic viruses and human immunodeficiency virus serological markers were negatives. We initially suspect the presence of an autoimmune disease and the patient was treated with steroids without improvement. After an extensive study including renal and bone marrow biopsy, a correct diagnosis of visceral leishmaniasis was made, and treatment with liposomal amphotericin B was initiated, achieving renal function recovery and normalization of immunological manifestations. CONCLUSIONS Renal involvement can be an important feature of VL and it might be associated with increased morbidity and mortality. The association between mixed cryoglobulinemia and renal involvement in VL have rarely been described. VL is frequently associated with diverse autoimmune manifestations and it can be initially misdiagnosed, which could lead to fatal consequences. The role of the immune system in the formation of cryoglobulins are discussed. In our case, an autoimmune disease was initially suspected, and starting treatment with steroids pulses was initiated. However, the presence of mixed cryoglobulinemia in this patient who was hepatitis C serological marker negative and who had poor renal function recovery after immunosuppressive treatment made us suspect other pathologies. The presence of cryoglobulinemia with renal disease in endemic areas of Leishmania should make us exclude this infection before starting immunosuppressive treatment.

Indexed as

AgedAmphotericin BAntiprotozoal AgentsBiopsyCryoglobulinemiaGlomerulonephritis, MembranoproliferativeHumansLeishmaniaLeishmaniasis, VisceralMaleRenal InsufficiencyUrineAmphotericin BAntiprotozoal Agentsliposomal amphotericin B

Identifiers

PMID32459796
PMCPMC7274496
OpenAlexW3031462710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.